High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations (Q60302093)

Xavier Matias-Guiu

0 references

C. Blake Gilks

C Blake Gilks

0 references

Esther Oliva

Esther Oliva

0 references

Glenn Mccluggage

W Glenn McCluggage

0 references

author name string

Rajmohan Murali

0 references

Ben Davidson

0 references

Oluwole Fadare

0 references

Joseph A Carlson

0 references

Christopher P Crum

0 references

Julie A Irving

0 references

Khush Mittal

0 references

Vinita Parkash

0 references

Joanne K L Rutgers

0 references

Paul N Staats

0 references

Colin J R Stewart

0 references

Carmen Tornos

0 references

Robert A Soslow

International Journal of Gynecological Pathology

0 references

language of work or name

English

0 references

publication date

January 2019

0 references

1 January 2019

3 references

19 June 2019

7 August 2019

29 May 2020

3 references

19 June 2019

7 August 2019

29 May 2020

38 Suppl 1

0 references

page(s)

S40-S63

0 references

Creative Commons Attribution

3 references

19 June 2019

7 August 2019

29 May 2020

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Mesonephroid (clear cell) carcinoma of the ovary and endometrium.A comparative prospective clinico-pathological study and review of literature

1 reference

12 December 2020

Clear cell carcinoma of the endometrium

1 reference

12 December 2020

Endometrial carcinoma in women under 40 years of age: comparison of cases in oral contraceptive users and non-users

1 reference

12 December 2020

Clear cell carcinoma of the endometrium: an analysis of 21 cases

1 reference

12 December 2020

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

1 reference

12 December 2020

Malignant mixed müllerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation

1 reference

12 December 2020

Primary clear cell carcinoma of the endometrium: a clinicopathologic study of 20 cases

1 reference

12 December 2020

Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases

1 reference

12 December 2020

Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases

1 reference

12 December 2020

Prognostic factors in malignant mesodermal (mullerian) mixed tumors of the uterus

1 reference

12 December 2020

Clear cell carcinoma of the endometrium

1 reference

12 December 2020

Secretory adenocarcinoma of the endometrium

1 reference

12 December 2020

Clear cell carcinoma of the endometrium. Clinical, pathologic, and ultrastructural findings

1 reference

12 December 2020

Endometrium with pattern of mesonephroma. Report of a case

1 reference

12 December 2020

A study of carcinoma of the endometrium

1 reference

12 December 2020

Mesenchymal tumors of the uterus. II. A clinical and pathologic study of 31 mixed mesodermal tumors

1 reference

12 December 2020

Mesenchymal tumors of the uterus. 3. A clinical and pathologic study of 31 carcinosarcomas

1 reference

12 December 2020

Serous papillary carcinoma of the endometrium. A clinicopathologic study of 11 cases.

1 reference

12 December 2020

Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma

1 reference

12 December 2020

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation

1 reference

12 December 2020

Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis

1 reference

12 December 2020

Low-stage clear-cell carcinoma of the endometrium

1 reference

12 December 2020

Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

1 reference

12 December 2020

Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern

1 reference

12 December 2020

p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis.

1 reference

12 December 2020

Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies

1 reference

12 December 2020

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression

1 reference

12 December 2020

Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma

1 reference

12 December 2020

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

1 reference

12 December 2020

Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma

1 reference

12 December 2020

Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract

1 reference

12 December 2020

Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population

1 reference

12 December 2020

Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects

1 reference

12 December 2020

Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

1 reference

12 December 2020

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

1 reference

12 December 2020

Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy

1 reference

12 December 2020

Clear-cell carcinoma of the endometrium

1 reference

12 December 2020

Differences in Treatment and Outcome Between African-American and White Women With Endometrial Cancer

1 reference

12 December 2020

Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects

1 reference

12 December 2020

Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?

1 reference

12 December 2020

Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium

1 reference

12 December 2020

Undifferentiated carcinoma of the endometrium

1 reference

12 December 2020

Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

1 reference

12 December 2020

Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?

1 reference

12 December 2020

Pathologic features of endometrial carcinoma associated with HNPCC

1 reference

12 December 2020

Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma

1 reference

12 December 2020

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

1 reference

12 December 2020

Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.

1 reference

12 December 2020

Undifferentiated carcinoma of the endometrium: a review

1 reference

12 December 2020

Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium

1 reference

12 December 2020

Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma

1 reference

12 December 2020

Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences

1 reference

12 December 2020

Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type

1 reference

12 December 2020

Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.

1 reference

12 December 2020

Determining predominating histologic component in malignant mixed müllerian tumors: is it worth it?

1 reference

12 December 2020

Prognostic features of surgical stage I uterine carcinosarcoma

1 reference

12 December 2020

Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review

1 reference

12 December 2020

The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma

1 reference

12 December 2020

Outcome of uterine clear cell carcinomas compared to endometrioid carcinomas and poorly-differentiated endometrioid carcinomas

1 reference

12 December 2020

Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases

1 reference

12 December 2020

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

1 reference

12 December 2020

The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium.

1 reference

12 December 2020

Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities

1 reference

12 December 2020

Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review

1 reference

12 December 2020

Association of clear cell carcinoma of the endometrium with a high rate of venous thromboembolism.

1 reference

12 December 2020

Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

1 reference

12 December 2020

p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes.

1 reference

12 December 2020

Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms

1 reference

12 December 2020

IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma.

1 reference

12 December 2020

Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study

1 reference

12 December 2020

High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes

1 reference

12 December 2020

A comparison of outcome in patients with stage 1 clear cell and grade 3 endometrioid adenocarcinoma of the endometrium with and without adjuvant therapy.

1 reference

12 December 2020

Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases

1 reference

12 December 2020

Endometrial carcinomas with ambiguous features.

1 reference

12 December 2020

Pathologic and molecular features of uterine carcinosarcomas

1 reference

12 December 2020

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma

1 reference

12 December 2020

Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study.

1 reference

12 December 2020

Two cases of low-grade endometriod carcinoma associated with undifferentiated carcinoma of the uterus (dedifferentiated carcinoma): a molecular study.

1 reference

12 December 2020

Expression of tissue factor and heparanase in endometrial clear cell carcinoma: possible role for tissue factor in thromboembolic events

1 reference

12 December 2020

Dedifferentiated endometrioid adenocarcinoma of the uterus: a clinicopathologic study of a case

1 reference

12 December 2020

IMP2 Expression Distinguishes Endometrioid From Serous Endometrial Adenocarcinomas

1 reference

12 December 2020

Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component

1 reference

12 December 2020

Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas

1 reference

12 December 2020

Comparison of Survival Outcomes Between Patients With Malignant Mixed Mullerian Tumors and High-Grade Endometrioid, Clear Cell, and Papillary Serous Endometrial Cancers

1 reference

12 December 2020

Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation

1 reference

12 December 2020

Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features

1 reference

12 December 2020

WT1 expression in the female genital tract

1 reference

12 December 2020

Ten problematical issues identified by pathology review for multidisciplinary gynaecological oncology meetings

1 reference

12 December 2020

P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin

1 reference

12 December 2020

Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression

1 reference

12 December 2020

HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis

1 reference

12 December 2020

Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report

1 reference

12 December 2020

Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma

1 reference

12 December 2020

Use of mutation profiles to refine the classification of endometrial carcinomas.

1 reference

12 December 2020

The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features

1 reference

12 December 2020

High-grade endometrial carcinomas - strategies for typing

1 reference

12 December 2020

Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases.

1 reference

12 December 2020

Undifferentiated endometrial carcinoma: a diagnosis frequently overlooked

1 reference

12 December 2020

Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance

1 reference

12 December 2020

The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium

1 reference

12 December 2020

Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.

1 reference

12 December 2020

ER+ /PR+ /TFF3+ /IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases.

1 reference

12 December 2020

Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma

1 reference

12 December 2020

Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis

1 reference

12 December 2020

ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma.

1 reference

12 December 2020

Reproducibility of histological cell type in high-grade endometrial carcinoma

1 reference

12 December 2020

ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas

1 reference

12 December 2020

Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis

1 reference

12 December 2020

HNF-1β in ovarian carcinomas with serous and clear cell change

1 reference

12 December 2020

Histotype-genotype correlation in 36 high-grade endometrial carcinomas.

1 reference

12 December 2020

Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor

1 reference

12 December 2020

Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas

1 reference

12 December 2020

Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility

1 reference

12 December 2020

Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry.

1 reference

12 December 2020

Molecular characterization of undifferentiated carcinoma associated with endometrioid carcinoma

1 reference

12 December 2020

Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin

1 reference

12 December 2020

PAX8 expression in uterine malignant mesodermal mixed tumor (carcinosarcoma)

1 reference

12 December 2020

Prognostic factors and treatment outcomes for patients with surgically staged uterine clear cell carcinoma focusing on the early stage: A Taiwanese Gynecologic Oncology Group study.

1 reference

12 December 2020

Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas

1 reference

12 December 2020

Dedifferentiated endometrioid adenocarcinoma of the uterus: highly aggressive and poor prognostic tumor.

1 reference

12 December 2020

Targeted mutation analysis of endometrial clear cell carcinoma.

1 reference

12 December 2020

The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry

1 reference

12 December 2020

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.

1 reference

12 December 2020

Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?

1 reference

12 December 2020

Endometrial Carcinomas With Clear Cells: A Study of a Heterogeneous Group of Tumors Including Interobserver Variability, Mutation Analysis, and Immunohistochemistry With HNF-1β.

1 reference

12 December 2020

Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma

1 reference

12 December 2020

Comparable outcome between endometrioid and non-endometrioid tumors in patients with early-stage high-grade endometrial cancer

1 reference

12 December 2020

Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant

1 reference

12 December 2020

Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.

1 reference

12 December 2020

Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer

1 reference

12 December 2020

Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.

1 reference

12 December 2020

SWI/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma.

1 reference

12 December 2020

A clinically applicable molecular-based classification for endometrial cancers

1 reference

12 December 2020

Fascin expression in undifferentiated and dedifferentiated endometrial carcinoma

1 reference

12 December 2020

Are clear cell carcinomas of the ovary and endometrium phenotypically identical? A proteomic analysis

1 reference

12 December 2020

Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers

1 reference

12 December 2020

Clinicopathologic and Immunohistochemical Characterization of Dedifferentiated Endometrioid Adenocarcinoma

1 reference

12 December 2020

Clear cell endometrial cancer: a CTF multicentre Italian study.

1 reference

12 December 2020

Failure to recognize preoperatively high-risk endometrial carcinoma is associated with a poor outcome.

1 reference

12 December 2020

Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.

1 reference

12 December 2020

Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers

1 reference

12 December 2020

Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma: Canadian Immunohistochemistry Quality Control (CIQC) Experience.

1 reference

12 December 2020

Immunohistochemical Profiling of Endometrial Serous Carcinoma.

1 reference

12 December 2020

CD34 expression in undifferentiated endometrial carcinoma

1 reference

12 December 2020

Integrated Molecular Characterization of Uterine Carcinosarcoma

1 reference

12 December 2020

The genetic landscape of endometrial clear cell carcinomas.

1 reference

12 December 2020